Cardiovascular Market Shows Robust Growth

China's market for lipid-lowering drugs such as statins, is set to double over the next four years according to industry estimates. Statins, which have driven sales for the major drug multinationals over past two decades, work by lowering cholesterol levels in people with or at risk from cardiovascular disease. With the US patents on the most popular treatments in this class set to run out in the next five years, BMI believes that emerging markets such as China and India could provide some much needed longevity to the

To read the full article, please choose one of the following options: